about
Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinomaThe prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma.Transcriptome analysis reveals dysregulated long non-coding RNAs and mRNAs associated with extrahepatic cholangiocarcinoma progression.Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma.ZEB1-AS1: A crucial cancer-related long non-coding RNA.Glucagon-like peptide-1 improves β-cell dysfunction by suppressing the miR-27a-induced downregulation of ATP-binding cassette transporter A1.Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway.Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.Long non-coding RNA MIAT in development and disease: a new player in an old game.Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinomaGlucagon-Like Peptide-1 Modulates Cholesterol Homeostasis by Suppressing the miR-19b-Induced Downregulation of ABCA1Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinomaAkirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathwayRadical modular pancreatoduodenectomy for pancreatic head cancer using a combination of multiple artery-first approaches techniqueUpregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosisEnhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivoColorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expressionIncreased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal PathwayUp-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5pLong non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinomaUpregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294The role of long non-coding RNA AFAP1-AS1 in human malignant tumorsmiR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in CholangiocarcinomaUp-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma
P50
Q33813109-B4D72CF4-F72F-412A-80B3-4F0C2C1460F2Q42371588-4F39263B-80F6-491E-91BE-7F5667E4CB44Q43128540-646CCEC0-230E-4E99-A994-0714E8D0A53BQ47156270-96DF387B-029D-4F98-B1EC-24A376AFC0C6Q47309299-CFCF02FD-8078-4DE1-9BAE-F5319DAA8A33Q47794143-43924A91-4E33-4DE1-A579-4676DA4F648DQ48016921-1EAA3BB6-A69A-4617-B0ED-1B174F3FDE47Q49795423-852C2663-49E4-4E75-B230-1754349D895BQ50033828-52448610-9908-47AB-B9CA-9234AA4553ECQ50064730-E4FEE809-B043-46C9-A81F-823FAEC9B07FQ50196675-56C2D006-6E4E-4C23-85D1-90BCB25C833EQ52593392-099DE857-EF5D-4241-A16C-B1D933199372Q52657624-E9B28439-C449-4270-9DC4-0B2DA1EAE808Q52867334-22FC1D15-576D-43FF-90E5-92D8B640DBD5Q57111846-A521BF8F-D3C2-491F-A8F2-BC5E22F184FBQ57279988-B98A2276-7A1D-4CE5-BD7B-85B352C83E8FQ64074920-9E0D6F36-2E65-4253-8E73-1A92D469AE0DQ64079084-4E2E0786-E610-400B-89BF-376B0C58B937Q64227617-9C7278E6-6818-4FC0-8592-2DEEFE6AC357Q88091013-E8679B4F-DA41-4C76-B3C7-B6C995BD2983Q89391503-60A63122-65B4-4052-8E58-8F7EA2AB72EAQ89741482-1DDD710B-9B8D-482C-AAC3-DAC4E80D9511Q90032190-0CAF9303-F2E2-44AD-A28F-13A712FDD744Q90359902-7FE9BB13-6B64-4476-B8F1-E1D483F712A2Q90731814-B7BAE75D-E024-442E-AD40-DE00D0650A8FQ90782945-D309FC7F-0DDB-4F65-8139-4EC20FD7B206Q91263473-D9F76791-1470-42EE-950B-183FF08567A1Q91581311-E8A5ECCE-B7C0-4A6C-B326-A6F59BBD89D0Q91776041-157DE7C4-9654-4329-92FE-7E19B5BE4549
P50
description
researcher (ORCID 0000-0003-2720-0005)
@en
name
Yi Xu
@en
type
label
Yi Xu
@en
prefLabel
Yi Xu
@en
P31
P496
0000-0003-2720-0005